The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology

INTRODUCTION: Adults with Down syndrome (DS) are at exceptionally high risk for Alzheimer's disease (AD), with virtually all individuals developing key neuropathological features by age 40. Identifying biomarkers of AD progression in DS can provide valuable insights into pathogenesis and sugges...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Alzheimers Dement (Amst)
Autores principales: Handen, Benjamin L., Lott, Ira T., Christian, Bradley T., Schupf, Nicole, OBryant, Sid, Mapstone, Mark, Fagan, Anne M., Lee, Joseph H., Tudorascu, Dana, Wang, Mei‐Cheng, Head, Elizabeth, Klunk, William, Ances, Beau, Lai, Florence, Zaman, Shahid, Krinsky‐McHale, Sharon, Brickman, Adam M., Rosas, H. Diana, Cohen, Annie, Andrews, Howard, Hartley, Sigan, Silverman, Wayne
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2020
Materias:
Review Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7396809/
https://ncbi.nlm.nih.gov/pubmed/32775597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12065
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares